j
formo
med
assoc
vol
sar
occur
taipei
municip
hope
hospit
northern
taiwan
unrecogn
index
patient
expos
multipl
patient
visitor
health
care
worker
outbreak
result
fatal
led
health
author
near
hospit
implement
control
procedur
nonetheless
earli
may
sar
infect
spread
multipl
citi
region
taiwan
larg
outbreak
kaohsiung
chang
gung
memori
hospit
cgmh
southern
taiwan
kaohsiung
cgmh
temporarili
discontinu
emerg
hospit
servic
end
sar
epidem
taiwan
juli
confirm
case
confirm
death
high
infect
hazard
global
health
scientist
attempt
develop
reliabl
test
find
effect
treatment
protocol
determin
key
epidemiolog
paramet
affect
spread
sarscov
previous
found
sar
patient
taiwan
appar
contact
histori
travel
histori
epidem
area
suggest
might
sporad
commun
spread
especi
taipei
citi
kaohsiung
citi
present
studi
use
two
serolog
method
survey
preval
sarscov
commun
adjac
kaohsiung
cgmh
nosocomi
outbreak
also
collect
demograph
data
includ
basic
inform
health
statu
household
possibl
risk
factor
sarscov
infect
conduct
survey
sarscov
seropreval
figur
select
three
precinct
district
within
three
citi
block
approxim
hospit
serolog
test
questionnair
survey
conduct
ageand
genderstratifi
sampl
use
household
registr
record
studi
subject
provid
written
inform
consent
particip
institut
review
board
cgmh
approv
studi
particip
complet
selfadminist
questionnair
collect
basic
demograph
data
includ
residenti
area
occup
health
care
worker
histori
chronic
diseas
epidem
quarantin
epidem
intrafamili
outsid
contact
sar
case
epidem
travel
histori
previou
month
classmat
neighbor
sar
epidem
public
convey
use
previou
month
ill
previou
month
prevent
measur
use
mask
peopl
use
mask
ask
specifi
mask
type
paper
surgic
defin
contact
sar
case
person
share
meal
resid
hospit
room
transport
vehicl
suspect
sar
patient
person
visit
suspect
sar
patient
within
day
patient
onset
symptom
also
consid
person
potenti
contact
secret
sar
patient
patient
treatment
care
close
contact
interview
subject
collect
ml
blood
sampl
sar
antibodi
detect
refriger
screen
sarscov
antibodi
use
whole
viral
lysat
enzymelink
immunosorb
assay
elisa
beij
huada
gbi
biotechnolog
co
ltd
beij
china
elisa
test
posit
use
indirect
immunofluoresc
assay
ifa
euroimmun
co
germani
retest
presenc
sarscov
antibodi
perform
igg
test
sarscov
indirect
elisa
test
use
lysat
whole
sarscov
coat
antigen
cutoff
valu
posit
igg
test
elisa
absorb
unit
neg
control
perform
ifa
test
use
dilut
serum
specimen
react
sarscovinfect
vero
cell
noninfect
cell
first
place
serial
dilut
serum
start
onto
well
slide
incub
minut
room
temperatur
wash
minut
twice
phosphatebuff
salin
pb
ad
dilut
fluoresceinlabel
antihuman
globulin
well
incub
minut
room
temperatur
wash
slide
twice
pb
observ
sampl
fluoresc
microscop
cutoff
valu
posit
igg
test
confid
interv
calcul
use
binomi
proport
function
built
sa
proc
freq
sa
version
sa
institut
inc
cari
nc
usa
randomli
select
resid
use
ageand
genderstratifi
sampl
method
household
registr
record
attempt
contact
person
telephon
exclud
subject
live
kaohsiung
citi
epidem
frequent
reason
given
refus
particip
tire
interview
reluct
disclos
person
inform
fear
discrimin
success
interview
obtain
blood
sampl
resid
none
subject
clinic
diagnosi
sar
quarantin
epidem
total
subject
underli
diseas
mild
moder
defin
mild
moder
underli
diseas
eg
allerg
diseas
atop
dermat
hepat
b
diseas
lifethreaten
result
immunodefici
analyz
factor
associ
sarscov
infect
stratifi
result
age
tabl
forti
subject
report
contact
quarantin
person
case
student
whose
classmat
famili
member
work
kaohsiung
cgmh
epidem
two
patient
sarscov
seroposit
confirm
ifa
report
contact
quarantin
person
epidem
none
quarantin
person
contact
subject
diagnos
sarsprob
case
epidem
analysi
select
factor
associ
sar
reveal
agespecif
sarscov
seroposit
rate
epidem
shown
tabl
person
seroposit
elisa
nearli
younger
year
age
use
ifa
method
confirm
presenc
sarscov
subject
posit
elisa
result
ifa
confirm
sarscov
two
case
year
age
found
sarsrel
risk
profil
sign
respiratori
tract
infect
two
patient
month
epidem
studi
provid
import
inform
potenti
spread
sar
hospit
local
commun
taiwanes
commun
studi
next
hospit
nosocomi
outbreak
studi
subject
commun
posit
elisa
ifa
result
sarscov
two
infect
patient
asymptomat
histori
contact
quarantin
individu
histori
travel
epidem
area
visit
hospit
nosocomi
outbreak
result
indic
limit
spread
sarscov
adjac
commun
follow
nosocomi
outbreak
previou
postepidem
serolog
survey
hong
kong
show
low
sarscov
seroposit
rate
asymptomat
close
contact
sar
patient
result
consist
find
anoth
sar
seropreval
studi
gener
practition
hong
kong
found
infect
rate
sarscov
atrisk
group
even
hospit
set
howev
seropreval
sar
health
care
worker
still
high
exampl
seropreval
studi
emerg
depart
worker
expos
sar
taiwanes
medic
center
found
incid
sarscov
infect
taken
togeth
previou
studi
indic
although
transmiss
sarscov
occur
primarili
hospit
set
transmiss
hospit
set
commun
gener
seriou
although
asymptomat
analysi
risk
factor
sarscov
transmiss
indic
subject
visit
hospit
sar
outbreak
occur
travel
affect
countri
contact
quarantin
individu
epidem
subject
report
use
mask
prevent
measur
infrequ
use
public
convey
previou
studi
show
use
mask
significantli
lower
risk
sarscov
transmiss
low
preval
sarscov
studi
popul
may
sarscov
transmit
via
direct
indirect
contact
mucou
membran
infecti
respiratori
droplet
howev
result
exclud
possibl
small
subclin
asymptomat
infect
sarscov
commun
previous
observ
hong
kong
three
test
use
diagnos
infect
sarscov
elisa
ifa
rtpcr
use
simpl
elisa
test
subject
ifa
subject
posit
elisa
result
ifa
highli
sensit
specif
labor
intens
antibodi
assay
base
virusinfect
cell
whole
viral
lysat
elisa
test
produc
fals
posit
close
relat
virus
coronavirida
particular
common
cold
associ
coronaviru
infect
highli
preval
whole
virusbas
assay
low
specif
use
diagnosi
sarscov
case
although
subject
seroposit
base
elisa
confirm
sarscov
infect
two
patient
precis
specif
ifa
similar
result
report
seropreval
studi
sar
infect
gener
practition
hong
kong
test
posit
elisa
none
test
posit
ifa
ifa
infect
cellbas
test
antisar
igg
antibodi
provid
high
sensit
specif
recent
studi
chan
et
al
show
sensit
specif
ifa
studi
found
low
postepidem
seropreval
sarscov
taiwanes
commun
adjac
hospit
nosocomi
outbreak
occur
find
support
previou
report
apriljuli
sar
outbreak
taiwan
primarili
limit
hospit
set
rare
transmiss
casual
social
contact
although
asymptomat
carrier
subclin
infect
occur
commun
present
studi
recent
studi
suggest
unlik
sourc
sar
reemerg
result
present
studi
prove
import
develop
implement
polici
control
sar
possibl
control
infecti
diseas
similar
mode
transmiss
